{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:42:20Z","timestamp":1787784140126,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13046-015-0279-6","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T18:29:04Z","timestamp":1452191344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer"],"prefix":"10.1186","volume":"35","author":[{"given":"Li","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghao","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoping","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiren","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,8]]},"reference":[{"issue":"2","key":"279_CR1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234\u201341.","journal-title":"Eur Urol"},{"issue":"4","key":"279_CR2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1349-7006.2008.00735.x","volume":"99","author":"WJ Kim","year":"2008","unstructured":"Kim WJ, Bae SC. Molecular biomarkers in urothelial bladder cancer. Cancer Sci. 2008;99(4):646\u201352.","journal-title":"Cancer Sci"},{"issue":"2","key":"279_CR3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1590\/S1677-55382012000200002","volume":"38","author":"GN Marta","year":"2012","unstructured":"Marta GN, Hanna SA, Gadia R, Correa SF, Silva JL, Carvalho HA. The role of radiotherapy in urinary bladder cancer: current status. Int Braz J Urol. 2012;38(2):144\u201353.","journal-title":"Int Braz J Urol"},{"issue":"3","key":"279_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000335556","volume":"88","author":"M Racioppi","year":"2012","unstructured":"Racioppi M, D\u2019Agostino D, Totaro A, Pinto F, Sacco E, D\u2019Addessi A, et al. Value of current chemotherapy and surgery in advanced and metastatic bladder cancer. Urol Int. 2012;88(3):249\u201358.","journal-title":"Urol Int"},{"issue":"1","key":"279_CR5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrg3094","volume":"13","author":"W Weber","year":"2012","unstructured":"Weber W, Fussenegger M. Emerging biomedical applications of synthetic biology. Nat Rev Genet. 2012;13(1):21\u201335.","journal-title":"Nat Rev Genet"},{"key":"279_CR6","first-page":"1802","volume":"7","author":"S Shankar","year":"2011","unstructured":"Shankar S, Pillai MR. Translating cancer research by synthetic biology. Mol Bio Syst. 2011;7:1802\u201310.","journal-title":"Mol Bio Syst"},{"issue":"2","key":"279_CR7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2013.10.038","volume":"65","author":"S Wu","year":"2014","unstructured":"Wu S, Huang P, Li C, Huang Y, Li X, Wang Y, et al. Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study. Eur Urol. 2014;65(2):274\u20137.","journal-title":"Eur Urol"},{"issue":"8","key":"279_CR8","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/1097-0142(20001015)89:8<1670::AID-CNCR4>3.0.CO;2-J","volume":"89","author":"H Saeki","year":"2000","unstructured":"Saeki H, Kuwano H, Kawaguchi H, Ohno S, Suqimachi K. Expression of ets-1 transcription factor is correlated with penetrating tumor progression in patients with squamous cell carcinoma of the esophagus. Cancer. 2000;89(8):1670\u20136.","journal-title":"Cancer"},{"issue":"1","key":"279_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1756-9966-30-31","volume":"30","author":"Z Lin","year":"2011","unstructured":"Lin Z, Liu Y, Sun Y, He X. Expression of Ets-1, Ang-2 and maspin in ovarian cancer and their role in tumor angiogenesis. J Exp Clin Cancer Res. 2011;30(1):31.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"279_CR10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/PAI.0b013e31821ba035","volume":"20","author":"A Sari","year":"2012","unstructured":"Sari A, Calli A, Gorqel SN, Altinboqa AA, Kara C, Dincel C, et al. Immunohistochemical determination of ETS-1oncoprotein expression in urothelial carcinomas of the urinary bladder. Appl Immunohistochem Mol Morphol. 2012;20(2):153\u20138.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"6 Pt 1","key":"279_CR11","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.ju.0000096060.92397.ed","volume":"170","author":"WM Linehan","year":"2003","unstructured":"Linehan WM, Walther MM, Zbar B. The genetic basis of cancer of the kidney. J Urol. 2003;170(6 Pt 1):2163\u201372.","journal-title":"J Urol"},{"issue":"1","key":"279_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Bio. 2008;9(1):47\u201359.","journal-title":"Nat Rev Mol Cell Bio"},{"issue":"4","key":"279_CR13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","volume":"74","author":"ZN Oltvai","year":"1993","unstructured":"Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74(4):609\u201319.","journal-title":"Cell"},{"issue":"1","key":"279_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1756-9966-33-53","volume":"33","author":"G Yang","year":"2014","unstructured":"Yang G, Zhang S, Zhang Y, Zhou Q, Peng S, Zhang T, et al. The inhibitory effects of extracellular ATP on the growth of nasopharyngeal carcinoma cells via P2Y2 receptor and osteopontin. J Exp Clin Cancer Res. 2014;33(1):53.","journal-title":"J Exp Clin Cancer Res"},{"key":"279_CR15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13046-015-0265-z","volume":"34","author":"S Zhao","year":"2015","unstructured":"Zhao S, Wang Q, Li Z, Ma X, Wu L, Ji H, et al. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-\u03baB activation in papillary thyroid carcinoma. J Exp Clin Cancer Res. 2015;34:146.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"279_CR16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-015-0258-y","volume":"34","author":"N Jaqadish","year":"2015","unstructured":"Jaqadish N, Parashar D, Gupta N, Aqarwal S, Purohit S, Kumar V, et al. A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer. J Exp Clin Cancer Res. 2015;34(1):142.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"279_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13046-015-0133-x","volume":"34","author":"T Wu","year":"2015","unstructured":"Wu T, Wang S, Wu J, Lin Z, Sui X, Xu X, et al. Icaritin induces lytic cytotoxicity in extranodal NK\/T-cell lymphoma. J Exp Clin Cancer Res. 2015;34(1):17.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"279_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13046-015-0134-9","volume":"34","author":"T Yang","year":"2015","unstructured":"Yang T, Shi R, Chang L, Tang K, Chen K, Yu G, et al. Huachansu suppresses human bladder cancer cell growth through the Fas\/Fasl and TNF- alpha\/TNFR1 pathway in vitro and in vivo. J Exp Clin Cancer Res. 2015;34(1):21.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"279_CR19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000778","volume":"5","author":"PC Hollenhorst","year":"2009","unstructured":"Hollenhorst PC, Chandler KJ, Poulsen RL, Johnson WE, Speck NA, Graves BJ. DNA specificity determinants associate with distinct transcription factor functions. PLoS Genet. 2009;5(12), e1000778.","journal-title":"PLoS Genet"},{"issue":"1","key":"279_CR20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030821","volume":"7","author":"D Senft","year":"2012","unstructured":"Senft D, Berking C, Graf SA, Kammerbauer C, Ruzicka T, Besch R. Selective induction of cell death in melanoma cell lines through targeting of Mcl-1 and A1. PLoS One. 2012;7(1), e30821.","journal-title":"PLoS One"},{"issue":"6","key":"279_CR21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.7150\/ijbs.5425","volume":"9","author":"XY Liu","year":"2013","unstructured":"Liu XY, Tang QS, Chen HC, Jiang XL, Fang H. Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity. Int J Biol Sci. 2013;9(6):564\u201377.","journal-title":"Int J Biol Sci"},{"issue":"106","key":"279_CR22","first-page":"8470","volume":"3","author":"YY Chen","year":"2011","unstructured":"Chen YY, Smolke CD. From DNA to targeted therapeutics: bringing synthetic biology to the clinic. Sci Transl Med. 2011;3(106):8470.","journal-title":"Sci Transl Med"},{"issue":"5","key":"279_CR23","first-page":"1285","volume":"11","author":"X Fu","year":"2015","unstructured":"Fu X, Liu Y, Zhuang C, Liu L, Cai Z, Huang W. Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637. Mol Bio Syst. 2015;11(5):1285\u20139.","journal-title":"Mol Bio Syst"},{"issue":"7","key":"279_CR24","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1007\/s13277-015-3169-9","volume":"36","author":"C Zhuang","year":"2015","unstructured":"Zhuang C, Fu X, Liu L, Liu YC, Huang WR, Cai ZM. Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer. Tumour Biol. 2015;36(7):5157\u201363.","journal-title":"Tumour Biol"},{"key":"279_CR25","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1038\/ncomms6393","volume":"5","author":"Y Liu","year":"2014","unstructured":"Liu Y, Zeng Y, Liu L, Zhuang C, Fu X, Huang W, et al. Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells. Nat Commun. 2014;5:5393.","journal-title":"Nat Commun"},{"issue":"5193","key":"279_CR26","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","volume":"266","author":"NW Kim","year":"1994","unstructured":"Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266(5193):2011\u20135.","journal-title":"Science"},{"issue":"3","key":"279_CR27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrc2275","volume":"8","author":"CB Harley","year":"2008","unstructured":"Harley CB. Telomerase and cancer therapeutics. Nat Rev Cancer. 2008;8(3):167\u201379.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"279_CR28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/8.1.137","volume":"8","author":"YS Cong","year":"1999","unstructured":"Cong YS, Wen J, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet. 1999;8(1):137\u201342.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"279_CR29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1139\/o11-037","volume":"89","author":"M Gladych","year":"2011","unstructured":"Gladych M, Wojtyla A, Rubis B. Human telomerase expression regulation. Biochem Cell Biol. 2011;89(4):359\u201376.","journal-title":"Biochem Cell Biol"},{"issue":"5","key":"279_CR30","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1007\/s11033-010-0439-x","volume":"38","author":"A Wojtyla","year":"2011","unstructured":"Wojtyla A, Gladych M, Rubis B. Human telomerase activity regulation. Mol Biol Rep. 2011;38(5):3339\u201349.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"279_CR31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1756-9966-32-38","volume":"32","author":"R Adamo","year":"2013","unstructured":"Adamo R, Comandini A, Aquino A, Bonmassar L, Guqlielmi L, Bonmassar E, et al. The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro. J Exp Clin Cancer Res. 2013;32(1):38.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6122","key":"279_CR32","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, et al. TERT promoter mutations in familial and sporadic melanoma. Science. 2013;339(6122):959\u201361.","journal-title":"Science"},{"issue":"6122","key":"279_CR33","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science. 2013;339(6122):957\u20139.","journal-title":"Science"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-015-0279-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T04:18:43Z","timestamp":1567484323000},"score":1,"resource":{"primary":{"URL":"http:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-015-0279-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,8]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["279"],"URL":"https:\/\/doi.org\/10.1186\/s13046-015-0279-6","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,8]]},"article-number":"3"}}